Phenotype Summary

Phenotypes

Publication	Data		Phenotype
Nagarajan et al., 2019	Fig. 5		spinal cord dorsal side has fewer parts of type oligodendrocyte, abnormal
Mathews et al., 2016	Fig. 1		oligodendrocyte MAPK cascade decreased occurrence, abnormal oligodendrocyte TOR signaling decreased occurrence, abnormal spinal cord oligodendrocyte ab1-rps6 labeling decreased amount, abnormal spinal cord oligodendrocyte ab20-mapk labeling decreased amount, abnormal
Boyd et al., 2015	Fig. 6		hindbrain glioblast (sensu Vertebrata) disc1 expression decreased amount, abnormal hindbrain glioblast (sensu Vertebrata) disc1 expression decreased distribution, abnormal hindbrain glioblast (sensu Vertebrata) EGFP expression decreased amount, abnormal hindbrain glioblast (sensu Vertebrata) EGFP expression decreased distribution, abnormal
	Fig. 7		glioblast (sensu Vertebrata) cell migration in hindbrain decreased occurrence, abnormal hindbrain glioblast (sensu Vertebrata) EGFP expression decreased amount, abnormal hindbrain glioblast (sensu Vertebrata) EGFP expression decreased distribution, abnormal oligodendrocyte differentiation disrupted, abnormal oligodendrocyte progenitor proliferation disrupted, abnormal
Kearns et al., 2015	Fig. 4		oligodendrocyte TOR signaling decreased occurrence, abnormal spinal cord oligodendrocyte ab1-rps6 labeling decreased amount, abnormal
Al Oustah et al., 2014	Fig. 7		smoothened signaling pathway involved in ventral spinal cord patterning decreased process quality, abnormal spinal cord has fewer parts of type oligodendrocyte, abnormal
Mathews et al., 2014	Fig. 4		oligodendrocyte development process quality, abnormal oligodendrocyte mislocalised dorsally, abnormal spinal cord oligodendrocyte far from dorsal longitudinal fasciculus, abnormal
	Fig. 5		oligodendrocyte development process quality, abnormal protein farnesylation process quality, abnormal protein geranylgeranylation process quality, abnormal spinal cord central nervous system myelination process quality, normal spinal cord oligodendrocyte dorsal to dorsal longitudinal fasciculus, abnormal spinal cord oligodendrocyte mislocalised dorsally, abnormal
	Fig. 7		cholesterol biosynthetic process process quality, abnormal spinal cord oligodendrocyte adjacent to dorsal longitudinal fasciculus, normal spinal cord oligodendrocyte position, normal
Kassen et al., 2009	Fig. 8		retina neuroblast (sensu Vertebrata) proliferative, abnormal